Jump to
For over a year now, Temasek has been very active in the fight against the COVID-19 pandemic.
Amid resurgences from more infectious new variants, we remain ready to lend a helping hand, knowing no one is safe till everyone is safe. We adapt to new challenges and work closely with Temasek Foundation to enhance the Stay Prepared initiatives for protecting people from the virus as best as we can.
Our Stay Prepared initiatives are centred on five areas: testing & diagnosis, containment & contact tracing, care & treatment, protection & prevention, and enablement.
To support overseas communities, Temasek Foundation provided some 40 countries essential medical supplies. In Singapore, we launched initiatives such as masks and sanitiser distribution exercises.
We helped to pilot COVID-19 screenings as our economy reopened.
We supported eight companies, including those from the construction and marine engineering sectors, to pilot Oneself-Swab-Oneself or OSO, for their own regular employee screenings. About 350 of their staff volunteered to be trained to do the nasopharyngeal and oropharyngeal plus mid-turbinate swab techniques. This OSO programme provided operational flexibility and efficiency to the companies, and enhanced Singapore’s nationwide swabbing capacities and build community resilience.
Temasek Foundation worked with several partners, public and private, to pilot the Antigen Rapid Test (ART) for on-site screenings at MICE events and social gatherings. Pilot trials were conducted at events such as conferences, concerts, sporting events and weddings to assess ART’s utility for pre-event screenings while minimising inconvenience caused to event participants.
Temasek Foundation worked with Indonesia’s Eka Hospital for field validation of the ART to provide results in 20 minutes, in comparison against paired Reverse Transcription PCR tests.
The study was successfully completed by Eka Hospital in February. The joint effort expanded the hospital’s COVID-19 screening capabilities while giving researchers valuable data on the sensitivity and specificity of ART kits. This study has helped to guide the use of ART in Singapore to pick up infectious cases early.
We pioneered initiatives for safe reopening of activities during the ongoing pandemic.
Temasek and Affinidi, our digital identity technology company, worked with industry partners and authorities for a universal verifier solution, Unifier, to authenticate COVID-19 vaccination and test results. This interoperable solution covers verifiable health credentials using different standards and formats of QR codes, and allows airlines and immigration authorities to tap into global private and public initiatives to reopen borders safely.
Temasek Foundation encouraged D’Crypt, one of our portfolio companies, to develop the BluePass automatic contact tracing device. Over 835,000 devices were deployed, including for residents and staff in migrant worker dormitories. This enables fast tracing of first degree contacts of COVID-19 cases that pop up. It facilitates second or third degree contacts for broader ring fencing of contacts, and may be used to identify potential sources of infection.
Several of our investee companies in our life sciences portfolio pivoted to support COVID-19 efforts.
Vir Biotechnology in the US made an early pivot to work on antibodies to treat COVID-19, whilst others work on using AI to identify existing drugs which could be repurposed or combined to treat COVID-19 at various stages of illness. In Singapore, our investee company, Tychan, has proprietary technologies that enable rapid design and development of antibody therapeutics for infectious diseases. Tychan developed a candidate antibody for COVID-19 within four months and conducted a Phase One safety trial with healthy volunteers in Singapore. A Phase Three efficacy trial is ongoing to determine the antibody’s effectiveness in reducing disease severity and/or shortening recovery time. The antibody, alongside existing vaccines and antiviral drugs, is potentially a valuable tool in the fight against COVID-19.
We continued to keep people safe with a nationwide distribution of hand sanitiser and increased efforts to raise public awareness of Singapore’s vaccination drive.
Temasek Foundation’s #BYOBclean initiative enabled Singapore households to collect 500ml of zero alcohol hand sanitisers. The first exercise last year benefited over 600,000 households. The second exercise this year saw the use of vending machines to dispense 115,000 litres of hand sanitiser. It was the first time that vending machines were used to dilute the sanitiser concentrate precisely, and automatically dispense the ready-to-use hand sanitiser into reusable bottles that residents brought along.
Temasek Foundation launched a public awareness campaign to educate the public on COVID-19 vaccinations. Media platforms such as newspapers and TV as well as social media platforms were used to encourage our residents to get vaccinated to protect themselves and their community. Our series of public service announcements and campaign to provide timely information and evidence-based assurance, underscore our commitment to protect people during the pandemic.
We supported frontliners in their fight against COVID-19, and provided assistance and relief wherever possible to vulnerable communities in and outside of Singapore amid the resurgence of COVID-19.
Temasek Trust launched the oscar@sg fund to catalyse ground-up projects that reflect the values of Ownership, Sustainability, Care, Assurance, Resilience (OSCAR). To date, the fund has empowered more than 200 projects covering diverse needs and beneficiary groups, and touched over 500,000 lives. Among them is Tak Takut Kids Club by 3Pumpkins, a community space open to children in Boon Lay, a neighbourhood in Singapore. It provides a safe space for children, especially those staying in public rental flats, to express themselves through the arts. Such projects help people and communities emerge stronger together.
Temasek Foundation joined our portfolio companies Singapore Airlines, Advanced MedTech (AMTH), SATS and Olam International, and other partners including Air India, Amazon India, Kerry Logistics, ACT Grants, Swasth Alliance, The Bajaj Group, Abhay Firodia Group, Star Agri, Thermax Limited, and Pune Platform, to send essential medical supplies to India.
To date, emergency medical supplies airlifted to India, include around 8,200 oxygen concentrators, 1,300 BiPAP positive airway pressure machines, 51,000 oximeters, and 37 AMTH’s ICU-grade Alpha ventilators equipped with remote monitoring and control capabilities, as well as other essential medical supplies.